Challenges in Diagnosing Primary Ciliary Dyskinesia and the Role of Nasal Nitric Oxide Testing: A Single Center Experience
Open Access
- 12 October 2026
- journal article
- research article
- Published by MDPI AG in Journal of Respiration
- Vol. 6 (4) , 28
Abstract
Rationale: Nasal nitric oxide (nNO) measurement is a recommended noninvasive screening tool for primary ciliary dyskinesia (PCD), but studies examining its real-world performance are limited, and integration of PCD diagnostic pathways varies across centers. Objective: The objective of this study was to evaluate the diagnostic utility of nNO, describe phenotypic profiles of patients with low and normal NO levels, and highlight the existing challenges in diagnosing PCD. Methods: We assessed the diagnostic performance of nNO testing in patients with suspected PCD, known PCD, or bronchiectasis/bronchiolitis with no known etiology who underwent nNO measurement using the velum closure technique between January 2023 and May 2025. We recorded and analyzed baseline clinical features, pulmonary function testing values, microbiologic data, and available genetic and other PCD diagnostic testing results. Results: Among 86 patients (mean age 30.4 ± 18.96 years; 61.6% female), 24 (27.9%) had low nNO (1) percent predicted (72.2 ± 23.0% vs. 84.5 ± 22.0%, p = 0.04) and had higher rates of Pseudomonas aeruginosa (54.2% vs. 25.8%, p = 0.02) compared with those with normal nNO. Conclusions: nNO testing performs well in the diagnostic evaluation of PCD among patients with clinical phenotypes suspicious for PCD. Substantial heterogeneity in the extent of PCD genetic testing was observed, underscoring the need to better define which patients may benefit from expanded PCD diagnostic evaluation or whole-genome sequencing (WGS). As there is no gold-standard diagnostic test for PCD, there is a need for further studies to refine diagnostic algorithms.Keywords
This publication has 23 references indexed in Scilit:
- The Genetics of Primary Ciliary Dyskinesia – Advances and LimitationsPediatric Pulmonology, 2026
- The utility of nasal nitric oxide in the diagnostic evaluation of primary ciliary dyskinesiaPediatric Pulmonology, 2024
- Cystic Fibrosis Carrier States Are Associated With More Severe Cases of BronchiectasisOpen Forum Infectious Diseases, 2024
- The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysisThe Lancet Respiratory Medicine, 2022
- Primary Ciliary DyskinesiaSeminars in Respiratory and Critical Care Medicine, 2021
- Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditionsProceedings of the National Academy of Sciences, 2019
- Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Prevalence of primary ciliary dyskinesia in consecutive referrals of suspect cases and the transmission electron microscopy detection rate: a systematic review and meta-analysisPediatric Research, 2016
- Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art reviewPediatric Pulmonology, 2015
- Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of researchGenetics in Medicine, 2014